Breaking News on Contract Research, Manufacturing & Clinical Trials

Library > On-Demand Supplier Webinar

Using FDA’s Draft Guidance on Risk-Based Monitoring to Improve Clinical Data Quality

Format: Webinar | Document type: Supplier Webinar
Related applications: Data management , Phase I-II , Phase III-IV

The Industry’s changing approach to clinical data monitoring requires the tools and team structure to effectively plan and execute risk-based monitoring. Join Lynn King and Rob Woolson as they discuss multi-disciplinary approaches to implementing alternative monitoring plans and specialized tools for successfully executing risk-based monitoring.


  • Lynn King, Assistant Vice President, Operations, Rho

    Lynn King

    Assistant Vice President, Operations


  • Rob Woolson, MS, Senior Biostatistician, Rho

    Rob Woolson, MS

    Senior Biostatistician